HPV阴性头颈部鳞状细胞癌术后放化疗患者的分子亚型分析及其与放射抵抗机制的关联
该多中心回顾性队列纳入128例接受术后放化疗的局部晚期HPV阴性头颈部鳞状细胞癌患者,进行基因表达分析并分为四种分子亚型。间质型肿瘤的局部区域控制率较低(p=0.012),且与上皮-间质转化增加及DNA修复基因富集的基因特征过表达相关。作者认为,经前瞻性验证后,基于亚型的患者分层可考虑用于未来个体化放疗的干预性研究。
要点
- 肿瘤分为基底型(19.5%)、间质型(18.8%)、非典型型(15.6%)和经典型(14.1%),其余32.0%无法分类。
- 间质型肿瘤的局部区域控制率低于其他亚型(p=0.012)。
- 间质型肿瘤与上皮-间质转化增加及DNA修复基因富集的基因特征过表达相关。
核心结论
- 既往在原发放化疗或手术治疗的HNSCC患者中识别的分子亚型,与接受术后放化疗患者的局部区域控制相关,其中间质型肿瘤预后较差。
- 作者认为,经前瞻性验证后,基于亚型的患者分层可考虑用于未来个体化放疗背景下的干预性研究,并可能指导联合治疗方案的开发。
研究设计与样本
- 多中心回顾性患者队列(N=128),来自德国癌症联盟放射肿瘤学组(DKTK-ROG),为接受术后放化疗的局部晚期HNSCC患者。
- 使用GeneChip Human Transcriptome Array 2.0进行基因表达分析,将肿瘤分配至四种分子亚型,并分析亚型与临床危险因素的相关性。
- 比较八种与放射抵抗机制相关的基因或基因特征的分类在分子亚型间的差异,终点局部区域控制(LRC)和总生存(OS)采用log-rank检验和Cox回归评估。
主要发现
- 肿瘤分为基底型(19.5%)、间质型(18.8%)、非典型型(15.6%)和经典型(14.1%),其余32.0%无法分类。
- 间质型肿瘤的LRC低于其他亚型(p=0.012)。
- 间质型肿瘤与上皮-间质转化(EMT)增加及DNA修复基因富集的基因特征过表达相关。
- 八种基因分类器中多数与整个队列的LRC或OS显著相关。
临床怎么用
- 作者认为,经前瞻性验证后,基于亚型的患者分层可考虑用于未来个体化放疗背景下的干预性研究,并可能指导联合治疗方案的开发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the relation of the previously reported classification of molecular subtypes to the outcome of patients with HNSCC treated with postoperative radio(chemo)therapy (PORT-C), and to assess the association of these subtypes with gene expressions reflecting known mechanisms of radioresistance. MATERIAL AND METHODS: Gene expression analyses were performed using the GeneChip Human Transcriptome Array 2.0 on a multicentre retrospective patient cohort (N = 128) of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG) with locally advanced HNSCC treated with PORT-C. Tumours were assigned to four molecular subtypes, and correlation analyses between subtypes and clinical risk factors were performed. In addition, the classifications of eight genes or gene signatures related to mechanisms of radioresistance, which have previously shown an association with outcome of patients with HNSCC, were compared between the molecular subtypes. The endpoints loco-regional control (LRC) and overall survival (OS) were evaluated by log-rank tests and Cox regression. RESULTS: Tumours were classified into the four subtypes basal (19.5%), mesenchymal (18.8%), atypical (15.6%) and classical (14.1%). The remaining tumours could not be classified (32.0%). Tumours of the mesenchymal subtype showed a lower LRC compared to the other subtypes (p = 0.012). These tumours were associated with increased epithelial-mesenchymal transition (EMT) and overexpression of a gene signature enriched in DNA repair genes. The majority of the eight considered gene classifiers were significantly associated to LRC or OS in the whole cohort. CONCLUSION: Molecular subtypes, previously identified on HNSCC patients treated with primary radio(chemo)therapy or surgery, were related to LRC for patients treated with PORT-C, where mesenchymal tumours presented with worse prognosis. After prospective validation, subtype-based patient stratification, potentially in combination with other molecular classifiers, may be considered in future interventional studies in the context of personalised radiotherapy and may guide the development of combined treatment approaches.
引用
- Patil S, Tawk B, Grosser M, et al. Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapy. Radiother Oncol. 2022. PMID: 34999136. doi:10.1016/j.radonc.2021.12.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。